- Last Close —
- Sector Healthcare
- Industry Diagnostics & Research
- Investment Style
- Day Range — – —
- Year Range — – —
- Market Cap —
- Volume / Avg — / —
- Price / Sales < 0.01
- Price / Book —
- Forward Div Yield —
- Trailing Div Yield —
Morningstar‘s Stock Analysis DDXSQ
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile DDXSQ
Diadexus Inc is a United States based diagnostics company. It develops and commercializes products that deliver healthcare providers with relevant information to assist in the management of their patients throughout the course of a cardiac disease. Its products include test kits for diagnosis of cardiovascular disease, liver disease, cancer markers, renal disease, diabetes, and electrolytes. Geographically the business presence of the firm is seen in the regions of US, Europe and rest of the world of which US region accounts for the majority of revenue.
South San Francisco, CA, 94080-1913
FAQs for Diadexus Inc Stock
No. DDXSQ does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
DDXSQ’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare DDXSQ’s historical performance against its industry peers and the overall market.